PSTV
Potential Price Increase for Plus Therapeutics Inc (PSTV) After Recent Insider Activity
Plus Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Potential Price Increase for Plus Therapeutics Inc (PSTV) After Recent Insider Activity
Plus Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Taking a Closer Look At Plus Therapeutics Inc (PSTV) Following Its Recent Trade
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
Plus Therapeutics Inc (PSTV) receives a Buy rating from D. Boral Capital
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
Plus Therapeutics Inc (PSTV) rating upgrades by D. Boral Capital
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
An Analysis of Plus Therapeutics Inc (PSTV)’s Potential Price Growth
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Investing in Plus Therapeutics Inc (PSTV): What You Must Know
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
Plus Therapeutics Inc’s latest rating changes from various analysts
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
